|
CC16-Derived Analogs for the Treatment of Inflammatory and Obstructive Lung Diseases
This innovation relates to analogs/mimetics of CC16 also known as Urinary protein 1 (UPI), or Clara cell protein, or club cell protein. This protein is targeted for the treatment of cancer, chronic obstructive pulmonary disease, asthma, cystic fibrosis and any other diseases that CC16 may have activity in. The inventors have discovered a novel site...
Published: 6/10/2024
|
Inventor(s): Julie Ledford, Josef Vagner, Stefano Guerra, Michael Johnson
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Biologics, Technology Classifications > Life Sciences > Small Molecules, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Healthcare Portfolios > Respiratory & Pulmonary
|
|
A Broad Spectrum Antimicrobial that Synergizes with Copper
University of Arizona researchers have developed an invention that synergizes with copper to kill and prevent further growth of a broad spectrum of pathogens (i.e both Streptococcus pneumoniae and Valley Fever with the potential to work on other pathogens). This therapy does not allow for resistance to be built by the microbes.
Published paper with...
Published: 1/5/2024
|
Inventor(s): Michael Johnson, Joseph Alvin, Angela Rivera, Wei Wang
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Therapeutics
|
|
Antibody Test for Coccidioidomycosis
This invention is a novel diagnostic test for coccidioidomycosis, also known as valley fever.
Background:
Valley fever (coccidioidomycosis) is a fungal disease that is a common cause for pneumonia due to spores that are swept through the air. The fungal infection can be identified in microscopic detection of specific cells within bodily fluids....
Published: 6/6/2024
|
Inventor(s): John Galgiani, Michael Johnson
Keywords(s):
Category(s): Technology Classifications > Veterinary Medicine > Diagnostics, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Healthcare Portfolios > Infectious Diseases
|
